Skip to content
Recall Observatory FDA recall evidence

Drug product

Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01

D-0651-2024

August 22, 2024

Class II

Product summary

Firm
ProRx LLC
Event
Event 95190
Status
Ongoing
Classification
Class II
Quantity
37 vials
Official record key
drug-enforcement:D-0651-2024

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot # ProRx040924-1, BUD 10/08/2024

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility